OG Kush is one of the most recognized cannabis strain names in North America and also one of the most misunderstood.
Patients visiting Pennsylvania’s 186+ licensed dispensaries frequently ask whether OG Kush is indica or sativa, expecting that answer to tell them how it will affect them.
The classification question has a short answer, but the more important answer is more nuanced: what actually predicts OG Kush’s therapeutic effect is its terpene profile and cannabinoid ratio, not its botanical label.
This guide covers both, along with everything Pennsylvania medical marijuana patients need to know before selecting an OG Kush product.
⚡ Quick Answer
OG Kush is a hybrid cannabis strain with indica-dominant characteristics, typically classified as approximately 55–60% indica, with THC ranging from 19–26% and CBD under 1%.
For Pennsylvania residents: OG Kush is legally accessible only through PA’s 186+ licensed dispensaries with a valid patient card. Smoking is prohibited under PA law, vaporization is the legal inhaled method.
Key Takeaways
- “Indica-dominant hybrid” is more accurate than either “indica” or “sativa”: OG Kush’s limonene content gives it a cerebral, uplifting character that contradicts the stereotypical “indica = couch-lock” assumption, making label-based selection unreliable.
- Limonene is the terpene most responsible for OG Kush’s anxiety-relevant effects, and limonene content varies significantly between batches; two OG Kush products at the same dispensary can have meaningfully different terpene profiles.
- OG Kush’s THC range (19–26%) is high enough to worsen anxiety in THC-sensitive patients, the same strain that relieves anxiety in one patient can trigger it in another, making start-low dosing non-negotiable.
- Pennsylvania’s per se DUI law applies, 75 Pa.C.S. § 3802(d) means any detectable THC metabolite in blood constitutes DUI regardless of card status, which matters for OG Kush’s longer-than-average THC detection window.
- Asking your PA dispensary pharmacist for the batch-specific COA is the only reliable way to know whether the OG Kush product in front of you is myrcene-dominant (more sedating) or limonene-dominant (more uplifting), the shelf label will not tell you.
Is OG Kush Indica or Sativa?
OG Kush is an indica-dominant hybrid, generally classified as approximately 55–60% indica and 40–45% sativa in its traditional phenotype.
It’s genetic lineage traces to a cross of Hindu Kush (a pure indica landrace from the Hindu Kush mountain range), Chemdawg (a high-potency hybrid), and Lemon Thai (a sativa-leaning landrace).
That combination is precisely why OG Kush does not behave like a straightforward indica: the sativa genetics from Lemon Thai and Chemdawg introduce a cerebral, mood-elevating component that many patients experience alongside the body relaxation typical of indica-leaning strains.
The “OG” designation has disputed origins, most commonly attributed to “Original Gangster” (a California street term for authenticity) or “Ocean Grown” (referencing its coastal California cultivation history). Neither origin changes the pharmacology.
PA Dispensary Reality Check: Because “OG Kush” is a popular brand name, PA dispensaries carry multiple OG Kush phenotypes and branded variants, including OG Kush #18, Fire OG, SFV OG, and others.
Each phenotype carries a distinct terpene profile. The strain name alone is not sufficient to predict effect. Always request the batch-specific Certificate of Analysis (COA), Pennsylvania’s 2025 DOH terpene labeling update requires full terpene disclosure on all licensed products.
Why the Indica/Sativa Label Matters Less Than the COA
As Ethan Russo established in his foundational 2011 paper in the British Journal of Pharmacology, the therapeutic character of a cannabis product is determined by its full cannabinoid and terpene profile, the entourage effect, not by its botanical classification.
The indica/sativa distinction was developed as a horticultural taxonomy. It was never designed as a pharmacological guide.
Two OG Kush products at two different PA dispensaries may carry the same label but express meaningfully different terpene ratios depending on cultivation conditions, genetics, and curing method.
The COA terpene panel is the only data point that tells you what a specific batch will actually do.
OG Kush Cannabinoid Profile
Cannabinoid Data Table
| Cannabinoid | Typical Range | Clinical Relevance for PA Patients |
|---|---|---|
| THC | 19–26% | Primary analgesic and anxiolytic effect; dose-dependent |
| CBD | <1% | Minimal CBD buffer — increases risk of THC-driven anxiety at high doses |
| CBG | Trace (<0.5%) | Emerging anti-inflammatory data; trace levels limit clinical contribution |
| THC:CBD Ratio | ~20:1 or higher | High-THC, low-CBD profile — not recommended as a first-choice for THC-sensitive patients |
OG Kush is a high-THC, low-CBD strain. This profile is relevant for PA patients for two reasons.
First, the absence of a meaningful CBD buffer means the full psychoactive impact of THC is not modulated, patients sensitive to anxiety or paranoia from THC should approach OG Kush with particular caution and begin with the smallest available dose.
Second, the high THC content provides pronounced analgesic and sedating effects that make OG Kush genuinely effective for patients with chronic pain and treatment-resistant insomnia, when used correctly.
Start low, go slow is not a cliché with OG Kush. It is clinical necessity.
Dispensary pharmacists in Pennsylvania consistently recommend new patients begin with the lowest available THC format, typically a vaporizer cartridge with a measured pull or a low-dose capsule, rather than beginning with flower at full potency.
OG Kush Terpene Profile
OG Kush is defined as much by its terpene profile as by its THC content. The characteristic fuel-and-pine aroma that dispensary patients immediately recognize is driven by its terpene matrix.
Understanding each dominant terpene helps PA patients use COA data to select the right OG Kush batch for their specific condition.
Myrcene
Myrcene is typically the most abundant terpene in OG Kush, driving its body-relaxing and sedating character.
Preclinical research has documented myrcene’s analgesic and anti-inflammatory properties, consistent with OG Kush’s reported effectiveness for chronic pain and muscle tension.
Myrcene also enhances cannabinoid permeability across the blood-brain barrier, which may potentiate THC’s effects at lower doses, an important consideration for PA patients calibrating their starting dose.
PA patient relevance: Batches with myrcene as the dominant terpene (above 0.5%) will lean more sedating. Best suited for evening or nighttime use, chronic pain, and insomnia.
Evidence level: Moderate (preclinical analgesic data; human observational data from cannabis cohorts)
Limonene
Limonene is the terpene most associated with OG Kush’s mood-elevating and anxiety-relieving character.
OG Kush’s fuel-citrus aroma is driven by limonene, which has documented anxiolytic activity in clinical models, including a 2019 human trial demonstrating significant reduction in anxiety scores following limonene inhalation.
For Pennsylvania’s largest patient population, the over 68% of PA MMJ patients certified for anxiety disorders (Drake et al., Annals of Internal Medicine, July 2025), limonene content is a primary factor in selecting an OG Kush batch.
PA patient relevance: Higher limonene batches are better suited to daytime anxiety management and stress relief. These batches will feel more “hybrid”, less couch-lock, more mood lift.
Evidence level: Moderate (human trial data for anxiolytic effect via inhalation)
Beta-Caryophyllene
Beta-caryophyllene (BCP) is the only terpene classified as a dietary cannabinoid, it binds selectively to CB2 receptors and produces anti-inflammatory effects without psychoactivity.
Published research has established BCP’s role as a functional CB2 agonist, relevant to both the inflammatory component of chronic pain and the neuroinflammatory mechanisms underlying anxiety disorders.
OG Kush reliably carries meaningful BCP levels, contributing to its anti-inflammatory therapeutic profile.
PA patient relevance: BCP’s CB2 activity complements THC’s CB1 activity, providing anti-inflammatory support that is particularly relevant for patients managing pain alongside anxiety.
Evidence level: Moderate (established CB2 binding mechanism; human pain data ongoing)
Linalool
Linalool appears in OG Kush at lower but clinically relevant levels. Its GABA-modulating anxiolytic activity contributes to OG Kush’s calming effect without adding to psychoactivity.
For PA patients who use OG Kush specifically for stress-triggered conditions, linalool co-expression alongside limonene amplifies the anxiolytic profile through complementary mechanisms.
Evidence level: Moderate (lavender inhalation RCT data; cannabis-specific preclinical data)
Alpha-Pinene
Alpha-pinene in OG Kush contributes the sharp pine note in the aroma and may provide a partial counterbalance to THC-induced short-term memory impairment.
Research on pinene’s acetylcholinesterase inhibiting properties suggests it may partially offset cognitive effects, relevant for PA patients who need functional clarity alongside pain or anxiety relief.
Evidence level: Preliminary (preclinical mechanism; human data limited)
OG Kush Terpene Profile Table
| Terpene | Aroma Character | Primary Effect | PA Patient Relevance | Evidence Level |
|---|---|---|---|---|
| Myrcene | Earthy, musky, herbal | Analgesic, sedating, BBB permeability | Evening pain/insomnia; potentiates THC | Moderate |
| Limonene | Citrus, fuel | Anxiolytic, mood-elevating | Anxiety, daytime stress relief | Moderate |
| Beta-caryophyllene | Spicy, pepper, woody | CB2 anti-inflammatory | Chronic pain, inflammation | Moderate |
| Linalool | Floral, lavender | GABA anxiolytic, calming | Stress-triggered conditions | Moderate |
| Alpha-pinene | Pine, fresh | Alertness, partial memory support | Functional daytime use | Preliminary |
Entourage Effect Note: OG Kush’s therapeutic profile is the product of all five of these terpenes operating together alongside THC, not any single compound in isolation.
A batch high in myrcene but low in limonene will feel very different from one with the reverse profile, even at the same THC percentage. This is why the COA terpene panel is the essential tool for PA patients, not the strain name.
Therapeutic Effects for PA Medical Patients
OG Kush’s effects, framed therapeutically for PA MMJ patients:
Commonly reported therapeutic effects:
- Reduction in acute and chronic pain perception
- Relief of anxiety and intrusive stress response
- Muscle relaxation and tension relief
- Sleep onset support in insomnia-comorbid patients
- Appetite stimulation relevant for patients experiencing nausea or cachexia
- Mood stabilization in patients with anxiety-depression comorbidity
Who Should Use Caution with OG Kush
OG Kush is a high-THC, low-CBD strain. The following patient profiles warrant particular caution or medical guidance before using OG Kush products:
- THC-naive patients: The 19–26% THC range is among the highest available at PA dispensaries; beginners should start with a lower-THC product and titrate toward OG Kush
- Patients with anxiety disorders who are THC-sensitive: OG Kush’s THC level can trigger or worsen anxiety at doses above the patient’s individual threshold
- Patients using CNS depressants: Myrcene-dominant OG Kush may potentiate the sedating effects of opioids, benzodiazepines, and antihistamines
- Patients with a history of THC-triggered psychosis or paranoia, high-THC strains are contraindicated in this population regardless of qualifying condition
- Patients who must drive or operate machinery: OG Kush’s high THC content and PA’s per se DUI law create significant legal exposure for patients who underestimate residual impairment
What Conditions Is OG Kush Used For?
Anxiety Disorder
Anxiety Disorder is Pennsylvania’s most frequently certified qualifying condition, cited in over 68% of all PA MMJ certifications.
OG Kush’s limonene-dominant batches are among the most commonly recommended products at PA dispensaries for anxiety patients, specifically because limonene’s documented anxiolytic mechanism aligns with the presenting symptom pattern.
However, the high THC:CBD ratio requires careful dose calibration. Dispensary pharmacists typically recommend low-dose vaporization over higher-dose edible formats for anxiety patients using OG Kush.
Severe Chronic or Intractable Pain
Severe Chronic or Intractable Pain is among the most common qualifying conditions for OG Kush users in PA dispensary settings.
OG Kush’s myrcene-driven analgesic profile, combined with high THC content and BCP’s CB2 anti-inflammatory activity, makes it a frequently recommended option for patients with musculoskeletal pain, neuropathic pain, and treatment-resistant chronic pain.
Evening or nighttime use is typically preferred given the sedating character of myrcene-dominant batches.
Neuropathies
Neuropathies: including peripheral neuropathic pain from diabetes, post-herpetic neuralgia, and chemotherapy-induced neuropathy, represent a qualifying condition where OG Kush’s THC-dominant analgesic profile has clinical relevance.
THC’s CB1-mediated modulation of pain signaling in peripheral nerve pathways is among the better-studied cannabinoid analgesic mechanisms in neuropathic pain conditions.
PTSD
PTSD patients in Pennsylvania frequently report using OG Kush for its combined anxiolytic and sleep-supporting effects.
The strain’s ability to reduce intrusive thought patterns (via limonene/linalool anxiolytic pathways) while supporting sleep onset (via myrcene sedation) addresses two of the most functionally impairing PTSD symptoms simultaneously.
Dispensary pharmacists typically recommend low-to-moderate doses and evening timing for PTSD patients.
OG Kush at Pennsylvania Dispensaries
OG Kush is one of the most widely stocked strain profiles at Pennsylvania’s 186+ licensed dispensaries as of July 2026.
Patients will find it available in multiple product formats, though availability varies by dispensary location and current batch inventory.
OG Kush Product Formats at PA Dispensaries
| Product Format | Onset | Duration | Best For | PA Legal? |
|---|---|---|---|---|
| Vaporized flower | 2–10 min | 1–3 hrs | Acute pain, acute anxiety | ✅ Yes |
| Vaporizer cartridge | 2–5 min | 1–3 hrs | Portable, dose-controlled | ✅ Yes |
| Oral capsule | 45–120 min | 6–8 hrs | Chronic pain, overnight sleep | ✅ Yes |
| Tincture (sublingual) | 15–45 min | 4–6 hrs | Titration, moderate onset | ✅ Yes |
| Concentrate (wax/shatter) | 2–5 min | 2–4 hrs | Severe/refractory pain | ✅ Yes |
| Topical | Minimal systemic | Ongoing | Localized muscle tension | ✅ Yes |
| Smoked flower | — | — | Any | ❌ Illegal in PA |
Important note on availability: Because OG Kush is tested and labeled per batch, the terpene profile and THC percentage can differ between two OG Kush products on the same shelf.
Always request the COA for the specific batch you are considering, not a generic product data sheet.
COA Guidance for PA OG Kush Patients
Pennsylvania’s 2025 DOH update requires full terpene profile disclosure on all licensed dispensary product COAs. When reviewing an OG Kush COA:
- Confirm the dominant terpene, is it myrcene-dominant (more sedating/analgesic) or limonene-dominant (more uplifting/anxiolytic)?
- Check the THC% against your tolerance, 19–26% is a wide range; a 19% batch and a 26% batch are meaningfully different products for dose-sensitive patients
- Note the batch date, terpene content degrades over time; prefer batches tested within the past three to four months
- Verify the batch number matches the COA you are reviewing
💡 Dispensary Pharmacist Tip: When you walk up to a PA dispensary counter, describe your symptoms, not the strain name. Say: “I have chronic anxiety and lower back pain.
I need something that won’t knock me out during the day but helps me sleep at night.” The pharmacist can cross-reference that symptom profile with current batch COA data more precisely than any strain name search.
Pennsylvania Legal Notes
Valid PA MMJ Card Required
Recreational cannabis remains illegal in Pennsylvania as of July 2026. All purchases at Pennsylvania’s licensed dispensaries require a valid patient card issued under Act 16 of 2016.
OG Kush is available legally only to registered PA MMJ patients with current card status.
Smoking Is Prohibited Under PA Law
Pennsylvania Act 16 explicitly prohibits smoking cannabis regardless of MMJ card status. Vaporization is the only legal inhaled delivery method for PA patients.
Patients who smoke OG Kush flower, even with a valid card are in violation of state law. Legal consumption methods include vaporization, oral capsules, edibles, sublingual tinctures, and topicals.
⚠️ Per Se DUI Law — Critical Warning for OG Kush Patients
75 Pa.C.S. § 3802(d) establishes Pennsylvania’s per se DUI standard: any detectable level of THC or THC metabolites in blood constitutes DUI, regardless of actual impairment, and regardless of MMJ card status.
The Pennsylvania Superior Court confirmed in Commonwealth v. Stone (2022) that a valid MMJ card is not a defense to a per se DUI charge. OG Kush’s high THC content (19–26%) produces metabolites that remain detectable in blood well after psychoactive effects have resolved.
Do not drive after using OG Kush. SB 63 and HB 983, proposed DUI reforms for MMJ patients are pending as of July 2026 and are not yet law.
Certification Fees
| Fee | Amount |
|---|---|
| Physician certification (new patient) | $159 |
| PA state registration fee | $50 |
| Total — new patient | $209 |
| Physician certification (renewal) | $149 |
| PA state registration fee | $50 |
| Total — renewal | $199 |
MMAP Fee Waiver: Patients who qualify for Medicaid, SNAP, WIC, CHIP, PACE, or PACENET may have the $50 state registration fee waived through Pennsylvania’s Medical Marijuana Access Program.
Certification is completed by telehealth, no in-person office visit required. Get certified at PennsylvaniaMarijuanaCards.com.
How to Choose the Right OG Kush Product?
- Start with the COA, not the label. Request the batch-specific Certificate of Analysis from your PA dispensary before selecting a product. Identify the dominant terpene and confirm the THC% aligns with your tolerance level.
- Match the terpene profile to your primary symptom. If anxiety is your primary concern, prioritize limonene-dominant OG Kush batches. If chronic pain or insomnia is primary, prioritize myrcene-dominant batches. For both, look for meaningful BCP content as an anti-inflammatory complement.
- Select the delivery format based on onset timing. Acute symptom flares call for vaporization (2–10 minute onset). Prophylactic or overnight relief calls for capsules or edibles (45–120 minutes, 6–8 hours duration).
- Begin at the lowest effective dose. OG Kush’s 19–26% THC range means the margin between therapeutic and anxiety-triggering is narrower than with lower-THC products. For vaporization, one measured pull and a 15-minute wait is the standard starting protocol. For capsules, begin with the lowest dose available.
- Titrate incrementally over multiple sessions. Cannabis dose-finding requires patience. Effects and tolerance accumulate across sessions. PA dispensary pharmacists can guide dose escalation based on your specific product format and symptom pattern.
⚠️ Pro Tip: If you have never used high-THC cannabis before, OG Kush is not the recommended starting point.
Ask your dispensary pharmacist about lower-THC alternatives with a similar terpene profile, such as products in the 12–15% THC range with comparable myrcene and limonene content and work your way toward OG Kush as tolerance establishes.
Frequently Asked Questions
Q: Is OG Kush indica or sativa?
A: OG Kush is an indica-dominant hybrid, typically classified as approximately 55–60% indica and 40–45% sativa. Its genetic lineage crosses Hindu Kush (a pure indica landrace), Chemdawg (a potent hybrid), and Lemon Thai (a sativa-leaning landrace), producing a strain with both body-relaxing indica characteristics and a cerebral, mood-elevating sativa component. The indica/sativa label alone does not reliably predict its effect on any individual patient, the batch-specific terpene profile on the COA is the pharmacologically meaningful data point for Pennsylvania MMJ patients.
Q: What terpenes are in OG Kush?
A: OG Kush’s dominant terpenes are myrcene, limonene, and beta-caryophyllene, with linalool and alpha-pinene present at lower but clinically relevant levels. Myrcene drives body relaxation and analgesic effect; limonene drives the anxiolytic and mood-elevating character; beta-caryophyllene provides CB2 anti-inflammatory activity; linalool adds GABA-mediated calming; and alpha-pinene contributes alertness and may partially offset short-term memory effects. The relative proportion of each terpene varies by batch, myrcene-dominant batches feel more sedating, while limonene-dominant batches feel more uplifting. Pennsylvania’s 2025 DOH terpene labeling requirements mean this data is always available on the product COA.
Q: What is OG Kush good for medically?
A: OG Kush is most commonly used in PA dispensary settings for anxiety, chronic pain, and stress-related insomnia. Its limonene content provides documented anxiolytic properties relevant to Pennsylvania’s largest qualifying patient population. Its myrcene-driven analgesic and sedating profile addresses chronic musculoskeletal and neuropathic pain. PTSD patients also frequently report benefit from OG Kush’s combined anxiety-reduction and sleep-support effects. Patients should note that OG Kush’s high THC:CBD ratio (approximately 20:1) means it is not appropriate as a first-choice product for THC-sensitive patients or those new to medical cannabis.
Q: How much THC does OG Kush have?
A: OG Kush typically tests at 19–26% THC across available PA dispensary batches, with CBD below 1%. This places it in the high-potency range, significantly above the 10–15% THC products typically recommended for cannabis-naive patients. Because THC percentage varies meaningfully across that 19–26% range, verifying the exact THC% on the batch-specific COA before purchasing is essential. A 19% batch and a 26% batch require meaningfully different dose calibration, particularly for patients with anxiety-related qualifying conditions.
Q: Is OG Kush available at Pennsylvania dispensaries?
A: Yes, OG Kush is one of the most widely available strain profiles across Pennsylvania’s 186+ licensed dispensaries as of July 2026. Availability varies by dispensary location, current batch inventory, and product format. PA dispensaries carry OG Kush in multiple formats including vaporizer cartridges, flower for vaporization, oral capsules, and tinctures. Multiple OG Kush phenotypes exist under different brand names (SFV OG, Fire OG, OG Kush #18), each with a distinct terpene profile, so requesting the batch COA for the specific product is always recommended.
Q: Can I get a PA medical marijuana card to access OG Kush?
A: Yes, most patients who seek OG Kush for anxiety or chronic pain meet Pennsylvania’s qualifying condition criteria. Anxiety Disorder and Severe Chronic or Intractable Pain are among Pennsylvania’s most commonly certified qualifying conditions. Neuropathies and PTSD are also qualifying conditions relevant to OG Kush users. A telehealth evaluation with a certifying physician determines which qualifying condition applies based on your documented medical history. The total cost for a new PA patient is $209 ($159 physician certification + $50 state registration fee), and the card is valid for one year. Patients on Medicaid, SNAP, WIC, CHIP, PACE, or PACENET may have the $50 state fee waived.
Q: Is OG Kush good for anxiety?
A: OG Kush can be effective for anxiety in PA dispensary patients, but the outcome is highly dose-dependent and patient-specific. Its limonene content has documented anxiolytic properties, and limonene-dominant OG Kush batches are among the products PA dispensary pharmacists most frequently recommend for anxiety patients. However, OG Kush’s high THC content (19–26%) can trigger or worsen anxiety in patients who are THC-sensitive, who use too large a dose, or who select a batch with low limonene and high myrcene. Starting with the lowest available dose, choosing limonene-forward batches confirmed by COA, and using vaporization rather than edibles (for better dose control) are the standard pharmacist recommendations for anxiety patients considering OG Kush.
Medically reviewed by Dr. Johnathon Chance Miller, MD (License #MD474783). This content is for educational purposes only and does not constitute medical advice. Cannabis affects individuals differently. Consult a licensed healthcare provider before using cannabis for any medical condition. Pennsylvania medical marijuana patients must follow all state laws regarding legal methods of consumption. Smoking cannabis is prohibited under PA law. Do not drive after consuming cannabis. THC metabolites remain detectable in blood after psychoactive effects resolve, Pennsylvania’s per se DUI law applies regardless of MMJ card status.
